Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.
Related Articles

News
UC San Diego Health Expands Leading-Edge Cancer Care in Hillcrest
February 5, 2019
sandiegobiotech
News
Comments Off on UC San Diego Health Expands Leading-Edge Cancer Care in Hillcrest

News
Not So Great Expectations: Pain in HIV Related to Brain’s Expectations of Relief
November 4, 2021
sandiegobiotech
News
Comments Off on Not So Great Expectations: Pain in HIV Related to Brain’s Expectations of Relief
Neuroimaging study reveals potential brain mechanism underlying chronic neuropathic pain in individuals with HIV. Findings may guide new clinical treatments targeting patients’ expectations for pain relief. Click here to view original post… […]

News
Bioengineering Alumnus on COVID-19 Antiviral Pill Development Team
February 24, 2022
sandiegobiotech
News, UCSD News
Comments Off on Bioengineering Alumnus on COVID-19 Antiviral Pill Development Team
Jacobs School of Engineering alumnus Britton Boras earned a Ph.D. in bioengineering in 2015, conducting research with Professor Andrew McCulloch on multi-scale modeling of biological systems.
[…]